expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
the one- time expense, normalized EBITDA in 2Q19 was Bt19,753mn, increasing 4% YoY and 4. 5% QoQ, while normalized net profit was Bt8,234mn, increasing 2.9% YoY and 8. 1% QoQ. In conclusion for 1H19
domestic sales 24.2% and export sales 75.8%. Gross profit was down from 33.6% to 25.8% due to low margin sale to B2B coupled with the increase in raw material and energy costs. Total expense was Baht 504.6
selling expenses 183.84 147.60 36.24 24.55 Finance cost 208.75 110.40 98.35 89.09 Total expenses 902.73 726.79 175.94 24.21 Share of profit (loss) on investment in associated company 196.23 (2.03) 198.26
Dollars. The Company reported total expenses of Baht 398.4 million, decreased by 16.5% compared with QoQ, mainly due to operating expense management and lower shutdown expense. As a result, the Company
. The company and its subsidiary recorded tax expense of 73 MTHB which mostly from reversal of deferred tax assets due to utilization of unused tax losses brought forward from previous year. * Note Please
426.73 million compared to the same period of the previous year resulting from the increasing of market share and the expansion of business area. 2. Total expense for the 1st Quarter ended 31 March 2020
/ from Baht 423 million in Q3’2018 to Baht 220 million in Q4’2018, primarily due to 1) seasonally softening demand from IUs during the holiday period, 2) seasonally high expense, 3) a 4.6% increase in gas
from disposal of all share which held in Patara Fine Thai Cuisine Pte. Ltd (Patara) and SK Catering Pte. Ltd (SKC) Singapore total 11 Thai restaurants in the 4th quarter of 2018. In second quarter of